↓ Skip to main content

Dove Medical Press

Article Metrics

Efficacy and Safety of Teprotumumab in Thyroid Eye Disease

Overview of attention for article published in Therapeutics and Clinical Risk Management, November 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
5 Mendeley
Title
Efficacy and Safety of Teprotumumab in Thyroid Eye Disease
Published in
Therapeutics and Clinical Risk Management, November 2021
DOI 10.2147/tcrm.s303057
Pubmed ID
Authors

Honeylen Maryl Teo, Terry J Smith, Shannon S Joseph

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 20%
Student > Doctoral Student 1 20%
Student > Master 1 20%
Unknown 2 40%
Readers by discipline Count As %
Agricultural and Biological Sciences 1 20%
Neuroscience 1 20%
Medicine and Dentistry 1 20%
Unknown 2 40%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 February 2022.
All research outputs
#3,935,221
of 21,769,404 outputs
Outputs from Therapeutics and Clinical Risk Management
#184
of 1,237 outputs
Outputs of similar age
#89,697
of 404,803 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 2 outputs
Altmetric has tracked 21,769,404 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,237 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 404,803 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them